All severe cases no./no. (%) | IV-Artesunate no./no. (%) | IV-Quinine no./no. (%) | P value | ||||
---|---|---|---|---|---|---|---|
Hospitalization, days, median (range) (n=133) | 4 | (0–28) | 4 | (0–28) | 4 | (0–27) | 0.070 |
Intensive care unit stay, days, median (range) (n=134) | 1 | (0–19) | 0 | (0–17) | 3 | (0–19) | 0.045 |
Negative blood smear, days, median (range) (n=104) | 3 | (0–21) | 2 | (0–8) | 4 | (1–21) | 0.000 |
Stepdown therapy | 130/150 | (87) | 88/99 | (89) | 42/51 | (82) | 0.265 |
IV adverse events | 15/131 | (11) | 7/89 | (8) | 8/42 | (19) | 0.061 |
Minor complication | 5/131 | (4) | 2/89 | (2) | 3/42 | (7) | 0.327 |
Serious complication | 4/131 | (3) | 3/89 | (3) | 1/42 | (2) | 1.000 |
Other complication | 6/131 | (5) | 2/89 | (2) | 4/42 | (10) | 0.083 |
Outcome | |||||||
Still hospitalized | 27/143 | (18) | 16/92 | (17) | 11/51 | (22) | 0.514 |
Discharged | 100/143 | (70) | 64/92 | (70) | 36/51 | (71) | 0.898 |
Deceased | 3/143 | (2) | 1/92 | (1) | 2/51 | (4) | 0.257 |